NPI: 1457797474 · SAN JOSE, CA 95128 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 05/16/2013
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 05/16/2013 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 11,831 | $330K |
| 2019 | 7,505 | $170K |
| 2020 | 6,673 | $166K |
| 2021 | 6,553 | $159K |
| 2022 | 5,367 | $138K |
| 2023 | 2,069 | $78K |
| 2024 | 1,447 | $125K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 12,182 | 2,072 | $1.00M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 13,130 | 1,149 | $108K |
| J1756 | Injection, iron sucrose, 1 mg | 3,503 | 1,081 | $33K |
| A4657 | Syringe, with or without needle, each | 1,348 | 1,024 | $16K |
| J1270 | Injection, doxercalciferol, 1 mcg | 8,363 | 970 | $7K |
| 83970 | 381 | 334 | $474.37 | |
| 82728 | 384 | 323 | $166.24 | |
| 83550 | 382 | 309 | $94.73 | |
| 83540 | 410 | 335 | $84.96 | |
| 85041 | 608 | 525 | $56.44 | |
| 85048 | 589 | 509 | $45.87 | |
| 82108 | 54 | 51 | $42.17 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 111 | 71 | $0.00 |